Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 3471-3480 Newer>

Pharmaceutical Executive February 1, 2007 Iaquinto & Palmisano	Medical Education: A Platform for Success By pumping the science behind a brand, pharmaceutical companies can garner early loyalist - before a drug even hits the market.
Pharmaceutical Executive February 1, 2007 Chris Saridakis	Alternative Media: Stop, Click, and Listen Flashier rich-media advertisements add flare and functionality to otherwise static ads.
Pharmaceutical Executive February 1, 2007 Bryan Luce	Toolkit: Going Head to Head More and more, drugs both new and old are having to justify their price tags by proving that they're stronger, more effective, safer, or easier to take than the competition.
Chemistry World February 14, 2007 Victoria Gill	Prescription-free Viagra From today, men in the UK will be able to buy Viagra from their pharmacist without a doctor's prescription. But the trial run of the scheme has fanned the flames of a controversy about how US drug company Pfizer markets the impotence drug.
The Motley Fool February 13, 2007 Brian Lawler	CVT, We Wait for Thee CV Therapeutics' angina treatment could be set for a big boost. But what investors are getting with CVT today is a specialty pharma that is rapidly burning the cash on its balance sheet.
The Motley Fool February 13, 2007 Brian Lawler	Rock-Solid News From Onyx Results show that the drug Nexavar works in another type of cancer. But investors need to consider other issues when taking a closer look at this pharma.
BusinessWeek February 19, 2007 Arlene Weintraub	How Gilead Primed The Pipeline Gilead's $2.5 billion purchase of Myogen offers instant diversification from its HIV drug focus.
The Motley Fool February 12, 2007 Rich Duprey	Dentsply's New Supply of Growth The dental supply company takes a short-term sales hit as it reworks its distribution program. Investors, take note.
The Motley Fool February 7, 2007 Brian Lawler	Mylan Adjusts to the Matrix The drugmaker got a bump from a new generic and settles in with its Matrix acquisition. Investors, take note.
Fast Company February 1, 2007 Kathryn Tuggle	Fast Talk: Marathon Man Medtronic's Stephen Oesterle gets patients to run 26 miles with him -- to promote the medical-device maker, of course -- and also to show the world that chronically sick people can live full lives.
<Older 3471-3480 Newer> Return to current articles.